Outstanding Poster Presentation Awards

About the Award

The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards. Awardees are honored through notification to all meeting attendees and receive a special certificate for their contributions 

Criteria and Selection

Any ASGCT Member or Associate Member who submits an abstract to the Annual Meeting is eligible to receive the award. For more information, review the abstract submission guidelines coming soon.

2017 Recipients

Veronique Bolduc, PhD, National Institute of Neurological Disorders and Stroke/NIH
A Dominant-Negative COL6A1 Pseudoexon Insertion Is Skippable Using Splice-Modulating Oligonucleotides

Florie Borel, PhD, University of Massachusetts Medical School
Editing out Five SERPINA1 Paralogs to Create a New Mouse Model of Genetic Emphysema

Joab Camarena and Carsten Charlesworth, Stanford University
Priming Hematopoietic Stem and Progenitor Cells for CRISPR/Cas9-Mediated Homologous Recombination

Jean-Baptiste Dupont, PhD, University of Washington
RNA-Seq Analysis of Canine X-Linked Myotubular Myopathy Muscles Before and After Gene Therapy

Vasiliki Giannakakos, Weill Cornell Medical College
Second Generation Anti-Cocaine Vaccine Based on Modified Adenovirus Capsid proteins

Shalini Kot, Queen’s University
Sandhoff (Hexb-/-) Mice Mount an Immune Response Towards the Novel Human Variant HexM Protein When Treated with scAAV9-HEXM

Vasco Meneghini, PhD, Imagine Institute
Genome-Wide Definition of Regulatory Regions and Transcripts During the Transition from Pluripotent to Neural-Restricted Stem Cells

Takafumi Nakamura, PhD, Tottori University
Preclinical Study of Tumor-Targeted and Armed Oncolytic Vaccinia Virus for Systemic Cancer Virotherapy

David Ojala, University of California Berkeley
A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons

Melissa A. Pegues, PhD, National Cancer Institute
Novel Anti-CD30 Chimeric Antigen Receptors with Fully-Human Variable Regions Function Better with a CD28 Domain Than with a 4-1BB Domain

Brenda J. Seymour,  Seattle Children’s Research Institute
Optimizing Safe, Long-Term BTK Expression by Use of Insulator and Endogenous Enhancer Elements in a LV Vector for Treatment of XLA

Ilya Shestopalov, PhD,  bluebird bio
Development of a Single-Cell PCR Assay to Quantify the Percentage of Cells Transduced with Lentiviral Vectors

Diogo Silva, Baylor College of Medicine
Preclinical Development of CD7 CAR T Cells for the Treatment of Acute Myeloid Leukemia

Daniel Abate-Daga, PhD, H. Lee Moffitt Cancer Center and Research Institute
Chimeric Antigen Receptors (CARs) Interact in cis with Key T-Cell Proteins, Affecting TCR and Cytokine Signaling, in an Antigen-Independent Fashion

Daniel R. Blessing, Lausanne University Hospital
Validation of Scalable and Compliant AAV Production

Daphne Chen, University of North Carolina at Chapel Hill
Enhanced CNS Specificity of Adeno-Associated Viral Vectors Created by DNA Shuffling and Directed Evolution

Marianne E. Goodwin, PhD, Stanford University
CRISPR-Based Gene Correction to Treat IPEX Syndrome

Reka Haraszti, University of Massachusetts Medical School
ARRDC1- and Histone-Enriched Exosomes Released from Starved Stem Cells Improve siRNA Transfer to Neurons

Stefan Horn, PhD, University Medical Center Hamburg-Eppendorf
Novel All-in-One LeGO-Tet Vectors: A Flexible Tool for the Analysis of Gene Functions by Conditional Expression

Jennielle Jobson, Icahn School of Medicine at Mount Sinai
T Cells Can Serve as a Vehicle for Factor IX Gene Replacement

Ryan W. Johnson, PhD, The Research Institute at Nationwide Childrens Hospital
AAV.ANO5 Rescue of Muscle Dysfunction in ANO5 Mutant Mice Provides a Pathway Toward Treatment of LGMD2L

Virender Kumar, PhD, University of Nebraska Medical Center
Delivery of Chemically Stabilized MicroRNA for Treatment of Liver Fibrosis

Mohube B. Maepa, PhD, University of the Witwatersrand
Sustained Inhibition of Hepatitis B Virus Replication with AAV Vectors Expressing Primary micro RNA Mimics

Brian Pollok, PhD, Propagenix Inc.
EpiX™: A Primary Epithelial Cell Bioproduction Technology Providing Genetic Stability, Cost Efficiency, and Enablement of Ex Vivo Genetic Engineering

Jorge Quintero, PhD, University of Kentucky
Using Deep Brain Stimulation Surgery as a Platform for Cell Therapy Delivery in Patients with Parkinson's Disease

Lawrence Tartaglia, PhD, Harvard Medical School
Alpha-Defensin 5 Augments the Immuno-Modulatory Responses Elicited by an Adenovirus 26 Vaccine Delivery Vector in the Context of a Listeria Challenge Model

Chiara Antoniani, Imagine Institute
Induction of Fetal Hemoglobin Synthesis in Human Erythroblasts by CRISPR/Cas9-Mediated Editing of the β-Globin Locus

Layal Antoury, Massachusetts General Hospital
Extracellular Vesicles as Gene Therapy Vehicles for Duchenne Muscular Dystrophy

Julien Baruteau, DM, University College London
Rescue and Phenotypic Correction in Argininosuccinate Lyase-Deficient Mice by AAV8.ASL Transfer

Anthony Fargnoli, PhD, Icahn School of Medicine at Mount Sinai
Molecular Cardiac Surgery Mediated SERCA2a Overexpression Demonstrates Enhanced Cardiac Function and Reduced Borderzone Apoptosis in a 6 Month Ovine Ischemic Cardiomyopathy Model

CĂ©cile Fortuny, University of California, Berkeley
Optimization of Mitochondrial AAV-Mediated Gene Delivery for Outer Retina and Glia

Thomas Gaj, PhD, University of California, Berkeley
Using CRISPR-Cas9 to Purge the Latent HIV Reservoir

William Jia, PhD, University of British Columbia
Oncolytic Virotherapy with Simultanously Enhanced Oncolytic Activity and Safety

Mathieu Mevel, PhD, Université de Nantes
Chem-AAV: Chemically Modified AAV for Gene Therapy

Randall Meyer, Johns Hopkins University
Biomimetic Artificial Antigen Presenting Cells Synergize with Anti-PD1 in the Treatment of Melanoma

Jan Panteli, PhD, Dimension Therapeutics
Rapid Characterization of Transient Transfection Conditions for Scalable Production of Adeno-Associated Virus (AAV) Using NanoSight NS300

Anastasia Papadopoulou, PhD, George Papanicolaou Hospital
Clinical Scale Production of Leukemia Specific T-Cells from Non-Transplantable Cord Blood Units as a Paradigm of Circular Economy

Mizuho Sato-Dahlman, PhD, University of Minnesota
A Fiber and Hexon-Modified Infectivity-Selective Oncolytic Adenovirus Escapes Liver Sequestration After Systemic Administration in a Pancreatic Cancer Model

Jaquelyn T. Zoine, Emory University
Engineering Ex Vivo Serum-Free Expanded γδ T Cells for the Treatment of Neuroblastoma



ASGCT 24th Annual Meeting

May 11-14, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.